Reactive oxygen species signals leading to vascular dysfunction and atherosclerosis

Genomic and Personalized Medicine, Two-Vol Set

Volumn , Issue , 2009, Pages 652-664

  Madamanchi, Nageswara R ^a   Vendrov, Aleksandr E ^a   Runge, Marschall S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884799753     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-369420-1.00056-1     Document Type: Chapter

References (139)

1. Abu-Soud H.M., Hazen S.L. Nitric oxide is a physiological substrate for mammalian peroxidases. J Biol Chem 2000, 275:33752-37524.
2. Ambrosio G., Golino P., Pascucci I., Rosolowsky M., Campbell W.B., DeClerck F., Tritto I., Chiariello M. Modulation of platelet function by reactive oxygen metabolites. Am J Physiol 1994, 267:H308-318.
3. Auge N., Garcia V., Maupas-Schwalm F., Levade T., Salvayre R., Negre-Salvayre A. Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways. Arterioscler Thromb Vasc Biol 2002, 22:1990-1995.
4. Baldus S., Eiserich J.P., Mani A., Castro L., Figueroa M., Chumley P., Ma W., Tousson A., White C.R., Bullard D.C., et al. Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest 2001, 108:1759-1770.
5. Baldus S., Koster R., Chumley P., Heitzer T., Rudolph V., Ostad M.A., Warnholtz A., Staude H.J., Thuneke F., Koss K., et al. Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease. Free Radic Biol Med 2005, 39:1184-1190.
6. Ballinger S.W., Patterson C., Knight-Lozano C.A., Burow D.L., Conklin C.A., Hu Z., Reuf J., Horaist C., Lebovitz R., Hunter G.C., et al. Mitochondrial integrity and function in atherogenesis. Circulation 2002, 106:544-549.
7. Barry-Lane P.A., Patterson C., van der Merwe M., Hu Z., Holland S.M., Yeh E.T., Runge M.S. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest 2001, 108:1513-1522.
8. Bauriedel G., Hutter R., Welsch U., Bach R., Sievert H., Luderitz B. Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability. Cardiovasc Res 1999, 41:480-488.
9. Bergt C., Pennathur S., Fu X., Byun J., O'Brien K., McDonald T.O., Singh P., Anantharamaiah G.M., Chait A., Brunzell J., et al. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc Natl Acad Sci USA 2004, 101:13032-13037.
10. Bhunia A.K., Han H., Snowden A., Chatterjee S. Redox-regulated signaling by lactosylceramide in the proliferation of human aortic smooth muscle cells. J Biol Chem 1997, 272:15642-15649.
11. Blankenberg S., Rupprecht H.J., Bickel C., Peetz D., Hafner G.Tiret.L., Meyer J. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 2001, 104:1336-1342.
12. Bolick D.T., Orr A.W., Whetzel A., Srinivasan S., Hatley M.E., Schwartz M.A., Hedrick C.C. 12/15-lipoxygenaseregulates intercellular adhesion molecule-1 expression andmonocyte adhesion to endothelium through activation of RhoAand nuclear factor-kappaB. Arterioscler Thromb Vasc Biol 2005, 25:2301-2307.
13. Bond M., Chase A.J., Baker A.H., Newby A.C. Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc Res 2001, 50:556-565.
14. Bonetti P.O., Lerman L.O., Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003, 23:168-175.
15. Bowie A., O'Neill L.A. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 2000, 59:13-23.
16. Bracken M.B. Genomic epidemiology of complex disease: the need for an electronic evidence-based approach to research synthesis. Am J Epidemiol 2005, 162:297-301.
17. Brandes R.P., Viedt C., Nguyen K., Beer S., Kreuzer J., Busse R., Gorlach A. Thrombin-induced MCP-1 expression involves activation of the p22phox-containing NADPH oxidase in human vascular smooth muscle cells. Thromb Haemost 2001, 85:1104-1110.
18. Brennan M.L., Penn M.S., Van Lente F., Nambi V., Shishehbor M.H., Aviles R.J., Goormastic M., Pepoy M.L., McErlean E.S., Topol E.J., et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003, 349:1595-1604.
19. Brown B.G., Crowley J. Is there any hope for vitamin E?. JAMA 2005, 293:1387-1390.
20. Burke T.M., Wolin M.S. Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation. Am J Physiol 1987, 252:H721-H732.
21. Casas J.P., Bautista L.E., Humphries S.E., Hingorani A.D. Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation 2004, 109:1359-1365.
22. Cesari M., Penninx B.W., Newman A.B., Kritchevsky S.B., Nicklas B.J., Sutton-Tyrrell K., Rubin S.M., Ding J., Simonsick E.M., Harris T.B., et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 2003, 108:2317-2322.
23. Channon K.M., Qian H., George S.E. Nitric oxide synthase in atherosclerosis and vascular injury: insights from experimental gene therapy. Arterioscler Thromb Vasc Biol 2000, 20:1873-1881.
24. Chen C.H., Cheng T.H., Lin H., Shih N.L., Chen Y.L., Chen Y.S., Cheng C.F., Lian W.S., Meng T.C., Chiu W.T., et al. Reactive Oxygen Species Generation Is Involved in Epidermal Growth Factor Receptor Transactivation through The Transient Oxidization of SHP-2 in Endothelin-1 Signaling Pathway in Rat Cardiac Fibroblasts. Mol Pharmacol 2006, 69:1347-1355.
25. Chen X.L., Tummala P.E., Olbrych M.T., Alexander R.W., Medford R.M. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res 1998, 83:952-959.
26. Chen X.L., Zhang Q., Zhao R., Ding X., Tummala P.E., Medford R.M. Rac1 and superoxide are required for the expression of cell adhesion molecules induced by tumor necrosis factor-alpha in endothelial cells. J Pharmacol Exp Ther 2003, 305:573-580.
27. Chiarugi P. PTPs versus PTKs: the redox side of the coin. Free Radic Res 2005, 39:353-364.
28. Christ M., Bauersachs J., Liebetrau C., Heck M., Gunther A., Wehling M. Glucose increases endothelial-dependent superoxide formation in coronary arteries by NAD(P)H oxidase activation: Attenuation by the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin. Diabetes 2002, 5:2648-2652.
29. Cominacini L., Anselmi M., Garbin U., Fratta Pasini A., Stranieri C., Fusaro M., Nava C., Agostoni P., Keta D., Zardini P., et al. Enhanced plasma levels of oxidized low-density lipoprotein increase circulating nuclear factor-kappa B activation in patients with unstable angina. J Am Coll Cardiol 2005, 46:799-806.
30. Cominacini L., Garbin U., Pasini A.F., Davoli A., Campagnola M., Contessi G.B., Pastorino A.M., Lo Cascio V. Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Free Radic Biol Med 1997, 22:117-127.
31. Cominacini L., Pasini A.F., Garbin U., Davoli A., Tosetti M.L., Campagnola M., Rigoni A., Pastorino A.M., Lo Cascio V., Sawamura T. Oxidized low density lipoprotein(ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem 2000, 275:12633-12638.
32. Costanzo A., Moretti F., Burgio V.L., Bravi C., Guido F., Levrero M., Puri P.L. Endothelial activation by angiotensin II through NFkappaB and p38 pathways: Involvement of NFkappaB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin. J Cell Physiol 2003, 195:402-410.
33. Cybulsky M.I., Iiyama K., Li H., Zhu S., Chen M., Iiyama M., Davis V., Gutierrez-Ramos J.C., Connelly P.W., Milstone D.S. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001, 107:1255-1262.
34. Cyrus T., Witztum J.L., Rader D.J., Tangirala R., Fazio S., Linton M.F., Funk C.D. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest 1999, 103:1597-1604.
35. Daugherty A., Dunn J.L., Rateri D.L., Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 1994, 94:437-444.
36. Dreher D., Jornot L., Junod A.F. Effects of hypoxanthine-xanthine oxidase on Ca2+ stores and protein synthesis in human endothelial cells. Circ Res 1995, 76:388-395.
37. Du X., Stocklauser-Farber K., Rosen P. Generation of reactive oxygen intermediates, activation of NF-kappaB, and induction of apoptosis in human endothelial cells by glucose: role of nitric oxide synthase?. Free Radic Biol Med 1999, 27:752-763.
38. El Bekay R., Alvarez M., Monteseirin J., Alba G., Chacon P., Vega A., Martin-Nieto J., Jimenez J., Pintado E., Bedoya F.J., et al. Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: Involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-kappaB. Blood 2003, 102:662-671.
39. Ermak G., Davies K.J. Calcium and oxidative stress: from cell signaling to cell death. Mol Immunol 2002, 38:713-721.
40. Evans J.L., Goldfine I.D., Maddux B.A., Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002, 23:599-622.
41. Fang X., Weintraub N.L., Rios C.D., Chappell D.A., Zwacka R.M., Engelhardt J.F., Oberley L.W., Yan T., Heistad D.D., Spector A.A. Overexpression of human superoxide dismutase inhibits oxidation of low-density lipoprotein by endothelial cells. Circ Res 1998, 82:1289-1297.
42. Frank G.D., Eguchi S., Inagami T., Motley E.D. N-acetylcysteine inhibits angiotensin II-mediated activation of extracellular signal-regulated kinase and epidermal growth factor receptor. Biochem Biophys Res Commun 2001, 280:1116-1119.
43. Frank G.D., Mifune M., Inagami T., Ohba M., Sasaki T., Higashiyama S., Dempsey P.J., Eguchi S. Distinct mechanisms ofreceptor and nonreceptor tyrosine kinase activation by reactive oxygen species in vascular smooth muscle cells: role of metallo-protease and protein kinase C-delta. Mol Cell Biol 2003, 23:1581-1589.
44. Fu X., Kassim S.Y., Parks W.C., Heinecke J.W. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem 2001, 276:41279-41287.
45. Gardemann A., Mages P., Katz N., Tillmanns H., Haberbosch W. The p22 phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals. Atherosclerosis 1999, 145:315-323.
46. Ghanim H., Garg R., Aljada A., Mohanty P., Kumbkarni Y., Assian E., Hamouda W., Dandona P. Suppression of nuclear factor-kappaB and stimulation of inhibitor kappaB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese. J Clin Endocrinol Metab 2001, 86:1306-1312.
47. Goebeler M., Kilian K., Gillitzer R., Kunz M., Yoshimura T., Brocker E.B., Rapp U.R., Ludwig S. The MKK6/p38 stress kinase cascade is critical for tumor necrosis factor-alpha-induced expression of monocyte-chemoattractant protein-1 in endothelial cells. Blood 1999, 93:857-865.
48. Gonzalez-Pacheco F.R., Caramelo C., Castilla M.A., Deudero J.J., Arias J., Yague S., Jimenez S., Bragado R., Alvarez-Arroyo M.V. Mechanism of vascular smooth muscle cells activation by hydrogen peroxide: role of phospholipase C gamma. Nephrol Dial Transplant 2002, 17:392-398.
49. Griendling K.K., FitzGerald G.A. Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation. 2003, 108:1912-1916.
50. Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994, 74:1141-1148.
51. Guzik T.J., Sadowski J., Guzik B., Jopek A., Kapelak B., Przybylowski P., Wierzbicki K., Korbut R., Harrison D.G., Channon K.M. Coronary Artery Superoxide Production and Nox Isoform Expression in Human Coronary Artery Disease. Arterioscler Thromb Vasc Biol 2006, 26:333-339.
52. Guzik T.J., West N.E., Black E., McDonald D., Ratnatunga C., Pillai R., Channon K.M. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation 2000, 102:1744-1747.
53. Heydeck D., Upston J.M., Viita H., Ylaä -Herttuala S., Stocker R. Oxidation of low-density lipoprotein by rabbit and human 15-lipoxygenase: prevalence of non-enzymatic reactions. J Lipid Res 2001, 42:1082-1088.
54. Ho F.M., Liu S.H., Liau C.S., Huang P.J., Lin-Shiau S.Y. High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3. Circulation 2000, 101:2618-2624.
55. Hsieh C.C., Yen M.H., Yen C.H., Lau Y.T. Oxidized low density lipoprotein induces apoptosis via generation of reactive oxygen species in vascular smooth muscle cells. Cardiovasc Res 2001, 49:135-145.
56. Hsu Y.H., Chen J.J., Chang N.C., Chen C.H., Liu J.C., Chen T.H., Jeng C.J., Chao H.H., Cheng T.H. Role of reactive oxygen species-sensitive extracellular signal-regulated kinase pathway in angiotensin II-induced endothelin-1 gene expression in vascular endothelial cells. J Vasc Res 2004, 41:64-74.
57. Huot J., Houle F., Marceau F., Landry J. Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ Res 1997, 80:383-392.
58. Hwang J., Kleinhenz D.J., Lassegue B., Griendling K.K., Dikalov S., Hart C.M. Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production. Am J Physiol Cell Physiol 2005, 288:C899-C905.
59. Inoue N., Takeshita S., Gao D., Ishida T., Kawashima S., Akita H., Tawa R., Sakurai H., Yokoyama M. Lysophosphatidylcholine increases the secretion of matrixmetalloproteinase 2 through the activation of NADH/NADPH oxidase in cultured aortic endothelial cells. Atherosclerosis 2001, 155:45-52.
60. Inoue I., Goto S., Matsunaga T., Nakajima T., Awata T., Hokari S., Komoda T., Katayama S. The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+, Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism. 2001, 50:3-11.
61. Inoue N., Kawashima S., Kanazawa K., Yamada S., Akita H., Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 1998, 97:135-137.
62. Khan B.V., Harrison D.G., Olbrych M.T., Alexander R.W., Medford R.M. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci USA. 1996, 93:9114-9119.
63. Kitagawa K., Matsumoto M., Sasaki T., Hashimoto H., Kuwabara K., Ohtsuki T., Hori M. Involvement of ICAM-1 in the progression of atherosclerosis in APOE-knockout mice. Atherosclerosis. 2002, 160:305-310.
64. Kreuzer J., Viedt C., Brandes R.P., Seeger F., Rosenkranz A.S., Sauer H., Babich A., Nurnberg B., Kather H., Krieger-Brauer H.I. Platelet-derived growth factor activates production of reactive oxygen species by NAD(P)H oxidase in smooth muscle cells through Gi1,2. FASEB J 2003, 17:38-40.
65. Kuhlencordt P.J., Gyurko R., Han F., Scherrer-Crosbie M., Aretz T.H., Hajjar R., Picard M.H., Huang P.L. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation. 2001, 104:448-454.
66. Kunsch C., Medford R.M. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 1999, 85:753-766.
67. Landmesser U., Cai H., Dikalov S., McCann L., Hwang J., Jo H., Holland S.M., Harrison D.G. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 2002, 40:511-515.
68. Landmesser U., Dikalov S., Price S.R., McCann L., Fukai T., Holland S.M., Mitch W.E., Harrison D.G. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 2003, 111:1201-1209.
69. Landmesser U., Merten R., Spiekermann S., Buttner K., Drexler H., Hornig B. Vascular extracellular superoxide dismutase activityin patients with coronary artery disease: Relation to endothelium-dependent vasodilation. Circulation 2000, 101:2264-2270.
70. Lapenna D., de Gioia S., Ciofani G., Mezzetti A., Ucchino S., Calafiore A.M., Napolitano A.M., Di Ilio C., Cuccurullo F. Glutathione-related antioxidant defenses in human atherosclerotic plaques. Circulation 1998, 97:1930-1934.
71. Laursen J.B., Rajagopalan S., Galis Z., Tarpey M., Freeman B.A., Harrison D.G. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 1997, 95:588-593.
72. Lee I.M., Cook N.R., Gaziano J.M., Gordon D., Ridker P.M., Manson J.E., Hennekens C.H., Buring J.E. Vitamin E in the primary prevention of cardiovascular disease and cancer: The Women's Health Study: A randomized controlled trial. JAMA 2005, 294:56-65.
73. Li J.M., Fan L.M., Christie M.R., Shah A.M. Acute tumor necrosis factor alpha signaling via NADPH oxidase in microvascular endothelial cells: Role of p47phox phosphorylation and binding to TRAF4. Mol Cell Biol 2005, 25:2320-2330.
74. Li L., Sawamura T., Renier G. Glucose enhances endothelial LOX-1 expression: Role for LOX-1 in glucose-induced human monocyte adhesion to endothelium. Diabetes 2003, 52:1843-1850.
75. Li L., Sawamura T., Renier G. Glucose enhanceshuman macrophage LOX-1 expression: Role for LOX-1 inglucose-induced macrophage foam cell formation. Circ. Res. 2004, 94:892-901.
76. Liao J.K. Clinical implications for statin pleiotropy. Curr Opin Lipidol 2005, 16:624-629.
77. Lin S.J., Shyue S.K., Hung Y.Y., Chen Y.H., Ku H.H., Chen J.W., Tam K.B., Chen Y.L. Superoxide dismutase inhibits the expression of vascular cell adhesion molecule-1 and intracellular cell adhesion molecule-1 induced by tumor necrosis factor-alpha in human endothelial cells through the JNK/p38 pathways. Arterioscler Thromb Vasc Biol 2005, 25:334-340.
78. Liu J., Yang F., Yang X.P., Jankowski M., Pagano P.J. NAD(P)H oxidase mediates angiotensin II-induced vascular macrophage infiltration and medial hypertrophy. Arterioscler Thromb Vasc Biol 2003, 23:776-782.
79. Lloyd-Jones D.M., Bloch K.D. The vascular biology of nitric oxide and its role in atherogenesis. Annu Rev Med 1996, 47:365-375.
80. Lonn E., Bosch J., Yusuf S., Sheridan P., Pogue J., Arnold J.M., Ross C., Arnold A., Sleight P., Probstfield J., et al. Effects of long-term vitamin E supplementation on cardiovascularevents and cancer: A randomized controlled trial. JAMA 2005, 293:1338-1347.
81. Lounsbury K.M., Hu Q., Ziegelstein R.C. Calcium signaling and oxidant stress in the vasculature. Free Radic Biol Med 2000, 28:1362-1369.
82. Luchtefeld M., Grote K., Grothusen C., Bley S., Bandlow N., Selle T., Struber M., Haverich A., Bavendiek U., Drexler H., et al. Angiotensin II induces MMP-2 in a p47phox-dependent manner. Biochem Biophys Res Commun 2005, 328:183-188.
83. Madamanchi N.R., Bukoski R.D., Runge M.S., Rao G.N. Arachidonic acid activates Jun N-terminal kinase in vascular smooth muscle cells. Oncogene 1998, 16:417-422.
84. Madamanchi N.R., Li S., Patterson C., Runge M.S. Reactive oxygen species regulate heat-shock protein 70 via the JAK/STAT pathway. Arterioscler Thromb Vasc Biol 2001, 21:321-326.
85. Madamanchi N.R., Li S., Patterson C., Runge M.S. Thrombin regulates vascular smooth muscle cell growth and heat shock proteins via the JAK-STAT pathway. J Biol Chem 2001, 276:18915-18924.
86. Madamanchi N.R., Moon S.K., Hakim Z.S., Clark S., Mehrizi A., Patterson C., Runge M.S. Differential activation of mitogenic signaling pathways in aortic smooth muscle cells deficient in superoxide dismutase isoforms. Arterioscler Thromb Vasc Biol 2005, 25:950-956.
87. Madamanchi N.R., Vendrov A., Runge M.S. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005, 25:29-38.
88. Madamanchi N.R., Tchivilev I., Runge M.S. Genetic markers of oxidative stress and coronary atherosclerosis. Curr Atheroscler Rep 2006, 8:177-183.
89. Maziere C., Auclair M., Rose-Robert F., Leflon P., Maziere J.C. Glucose-enriched medium enhances cell-mediated low density lipoprotein peroxidation. FEBS Lett 1995, 363:277-279.
90. Mehrabian M., Allayee H., Wong J., Shi W., Wang X.P., Shaposhnik Z., Funk C.D., Lusis A.J. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosissusceptibility in mice. Circ Res 2002, 91:120-126.
91. Moreno M.U., Jose G.S., Fortuno A., Beloqui O., Diez J., Zalba G. The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension. J Hypertens 2006, 24:1299-1306.
92. Munzel T., Keaney J.F. Are ACE inhibitors a "magic bullet" against oxidative stress?. Circulation 2001, 104:1571-1574.
93. Natarajan R., Reddy M.A., Malik K.U., Fatima S., Khan B.V. Signaling mechanisms of nuclear factor-kappab-mediated activation of inflammatory genes by 13-hydroperoxyoctadecadienoic acid in cultured vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2001, 21:1408-1413.
94. Ohara Y., Peterson T.E., Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993, 91:2546-2551.
95. Ozaki M., Kawashima S., Yamashita T., Hirase T., Namiki M., Inoue N., Hirata K., Yasui H., Sakurai H., Yoshida Y., et al. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J Clin Invest 2002, 110:331-340.
96. Park J.Y., Park K.G., Kim H.J., Kang H.G., Ahn J.D., Kim H.S., Kim Y.M., Son S.M., Kim I.J., Kim Y.K., et al. The effects of the overexpression of recombinant uncoupling protein 2 on proli-feration, migration and plasminogen activator inhibitor 1 expression in human vascular smooth muscle cells. Diabetologia 2005, 48:1022-1028.
97. Patterson C., Ruef J., Madamanchi N.R., Barry-Lane P., Hu Z., Horaist C., Ballinger C.A., Brasier A.R., Bode C., Runge M.S. Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo. J Biol Chem 1999, 274:19814-19822.
98. Pedruzzi E., Guichard C., Ollivier V., Driss F., Fay M., Prunet C., Marie J.C., Pouzet C., Samadi M., Elbim C., et al. NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol Cell Biol 2004, 24:10703-10717.
99. Peng H.B., Libby P., Liao J.K. Induction and stabilization of IkB-a by nitric oxide mediates inhibition of NF-kB. J Biol Chem 1995, 270:14214-14219.
100. Pennathur S., Bergt C., Shao B., Byun J., Kassim S.Y., Singh P., Green P.S., McDonald T.O., Brunzell J., Chait A., et al. Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species. J Biol Chem 2004, 279:42977-42983.
101. Pieper G.M., Riaz-ul-Haq Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: Prevention by calphostin C. J Cardiovasc Pharmacol 1997, 30:528-532.
102. Pietersma A., Tilly B.C., Gaestel M., de Jong N., Lee J.C., Koster J.F., Sluiter W. p38 mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level. Biochem Biophys Res Commun 1997, 230:44-48.
103. Quyyumi A.A., Dakak N., Andrews N.P., Gilligan D.M., Panza J.A., Cannon R.O. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation 1995, 92:320-326.
104. Rahman A., Anwar K.N., Minhajuddin M., Bijli K.M., Javaid K., True A.L., Malik A.B. cAMP targeting of p38 MAP kinase inhibits thrombin-induced NF-kappaB activation and ICAM-1 expression in endothelial cells. Am J Physiol Lung Cell Mol Physiol 2004, 287:L1017-1024.
105. Rao G.N., Katki K.A., Madamanchi N.R., Wu Y., Birrer M.J. JunB forms the majority of the AP-1 complex and is a target for redox regulation by receptor tyrosine kinase and G protein-coupled receptor agonists in smooth muscle cells. J Biol Chem 1999, 274:6003-6010.
106. Ridker P.M., Hennekens C.H., Roitman-Johnson B., Stampfer M.J., Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998, 351:88-92.
107. Ritchie M.E. Nuclear factor-kappaB is selectively and markedly activated in humans with unstable angina pectoris. Circulation 1998, 98:1707-17013.
108. Robinson J.G., Smith B., Maheshwari N., Schrott H. Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis. J Am Coll Cardiol 2005, 46:1855-1862.
109. Romashkova J.A., Makarov S.S. NF-kB is a target of Akt in anti-apoptotic PDGF signalling. Nature 1999, 401:86-90.
110. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999, 340:115-126.
111. Schachinger V., Britten M.B., Dimmeler S., Zeiher A.M. NADH/NADPH oxidase p22 phox gene polymorphism is associated with improved coronary endothelial vasodilator function. Eur Heart J 2001, 22:96-101.
112. Shaw S., Wang X., Redd H., Alexander G.D., Isales C.M., Marrero M.B. High glucose augments the angiotensinII-induced activation of JAK2 in vascular smooth muscle cells via the polyol pathway. J Biol Chem 2003, 278:30634-30641.
113. Shen W.L., Gao P.J., Che Z.Q., Ji K.D., Yin M., Yan C., Berk B.C., Zhu D.L. NAD(P)H oxidase-derived reactive oxygen species regulate angiotensin-II induced adventitial fibroblast phenotypic differentiation. Biochem Biophys Res Commun 2006, 339:337-343.
114. Shin E.A., Kim K.H., Han S.I., Ha K.S., Kim J.H., Kang K.I., Kim H.D., Kang H.S. Arachidonic acid induces the activation of the stress-activated protein kinase, membrane ruffling and H2O2 production via a small GTPase Rac1. FEBS Lett. 1999, 452:355-359.
115. Spiekermann S., Landmesser U., Dikalov S., Bredt M., Gamez G., Tatge H., Reepschlager N., Hornig B., Drexler H., Harrison D.G. Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: Relation to endothelium-dependent vasodilation. Circulation 2003, 107:1383-1389.
116. Sugiyama M., Ohashi M., Takase H., Sato K., Ueda R., Dohi Y. Effects of atorvastatin on inflammation and oxidative stress. Heart Vessels 2005, 20:133-136.
117. Sundaresan M., Yu Z.X., Ferrans V.J., Irani K., Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995, 270:296-299.
118. Teissier E., Nohara A., Chinetti G., Paumelle R., Cariou B., Fruchart J.C., Brandes R.P., Shah A., Staels B. Peroxisome proliferator-activated receptor alpha induces NADPH oxidase activity in macrophages, leading to the generation of LDL with PPAR-alpha activation properties. Circ Res 2004, 95:1174-1182.
119. Tritto I., Ambrosio G. The multi-faceted behavior of nitric oxide in vascular "inflammation": catchy terminology or true phenomenon?. Cardiovasc Res 2004, 63:1-4.
120. Tritto I., D'Andrea D., Eramo N., Scognamiglio A., De Simone C., Violante A., Esposito A., Chiariello M., Ambrosio G. Oxygen radicals can induce preconditioning in rabbit hearts. Circ Res 1997, 80:743-748.
121. Tummala P.E., Chen X.L., Sundell C.L., Laursen J.B., Hammes C.P., Alexander R.W., Harrison D.G., Medford R.M. Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis. Circulation 1999, 100:1223-1229.
122. Ushio-Fukai M., Alexander R.W., Akers M., Griendling K.K. p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 1998, 273:15022-15029.
123. Ushio-Fukai M., Griendling K.K., Becker P.L., Hilenski L., Halleran S., Alexander R.W. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2001, 21:489-495.
124. Vasquez-Vivar J., Kalyanaraman B., Martasek P., Hogg N., Masters B.S., Karoui H., Tordo P., Pritchard K.A. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA 1998, 95:9220-9225.
125. Vendrov A.E., Madamanchi N.R., Hakim Z.S., Rojas M., Runge M.S. Thrombin and NAD(P)H oxidase-mediated regulation of CD44 and BMP4-Id pathway in VSMC, restenosis, and atherosclerosis. Circ Res 2006, 98:1254-1263.
126. Warnholtz A., Nickenig G., Schulz E., Macharzina R., Brasen J.H., Skatchkov M., Heitzer T., Stasch J.P., Griendling K.K., Harrison D.G., et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: Evidence for involvement of the renin-angiotensin system. Circulation 1999, 99:2027-2033.
127. Wassmann S., Laufs U., Baumer A.T., Muller K., Konkol C., Sauer H., Bohm M., Nickenig G. Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: Involvement of angiotensin AT1 receptor expression and Rac1 GTPase. Mol Pharmacol 2001, 59:646-654.
128. Wassmann S., Laufs U., Muller K., Konkol C., Ahlbory K., Baumer A.T., Linz W., Bohm M., Nickenig G. Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol 2002, 22:300-305.
129. Whiteside S.T., Israel A. I kappa B proteins: structure, function and regulation. Semin Cancer Biol 1997, 8:75-82.
130. Wilson S.H., Caplice N.M., Simari R.D., Holmes D.R., Carlson P.J., Lerman A. Activated nuclear factor-kappaB is present in the coronary vasculature in experimental hypercholesterolemia. Atherosclerosis 2000, 148:23-30.
131. Wu R.F., Xu Y.C., Ma Z., Nwariaku F.E., Sarosi G.A., Terada L.S. Subcellular targeting of oxidants during endothelial cell migration. J Cell Biol 2005, 171:893-904.
132. Wung B.S., Ni C.W., Wang D.L. ICAM-1 induction by TNFalpha and IL-6 is mediated by distinct pathways via Rac in endothelial cells. J Biomed Sci 2005, 12:91-101.
133. Yang H., Roberts L.J., Shi M.J., Zhou L.C., Ballard B.R., Richardson A., Guo Z.M. Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E. Circ Res 2004, 95:1075-1081.
134. Yla-Herttuala S., Rosenfeld M.E., Parthasarathy S., Glass C.K., Sigal E., Witztum J.L., Steinberg D. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc Natl Acad Sci USA 1990, 87:6959-6963.
135. Yoon S.O., Park S.J., Yoon S.Y., Yun C.H., Chung A.S. Sustained production of H(2)O(2) activates pro-matrix metalloproteinase-2 through receptor tyrosine kinases/phosphatidylinositol 3-kinase/NF-kappa B pathway. J Biol Chem 2002, 277:30271-30282.
136. Zalba G., Beloqui O., San Jose G., Moreno M.U., Fortuno A., Diez J. NADPH oxidase-dependent superoxide production is associated with carotid intima-media thickness in subjects free of clinical atherosclerotic disease. Arterioscler Thromb Vasc Biol 2005, 25:1452-1457.
137. Zeiher A.M., Fisslthaler B., Schray-Utz B., Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res 1995, 76:980-986.
138. Zhang R., Brennan M.L., Shen Z., MacPherson J.C., Schmitt D., Molenda C.E., Hazen S.L. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem 2002, 277:46116-46122.
139. Zheng L., Nukuna B., Brennan M.L., Sun M., Goormastic M., Settle M., Schmitt D., Fu X., Thomson L., Fox P.L., et al. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 2004, 114:529-541.